| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.904 | 0.003 | 0.904 | Platelet aggregation inhibitor | 0.833 0.004 DBMET01582 0.858 0.004 DBMET00348 0.821 0.004 DBMET00112 0.756 0.004 DBMET02467 0.565 0.006 DBMET02468 | ||
| 0.902 | 0.004 | 0.902 | Anticonvulsant | 0.486 0.013 DBMET01582 0.694 0.005 DBMET00348 0.852 0.004 DBMET00112 0.596 0.007 DBMET02467 0.35 0.029 DBMET02468 | ||
| 0.889 | 0.003 | 0.889 | Platelet activating factor antagonist | 0.766 0.004 DBMET01582 0.819 0.003 DBMET00348 0.744 0.004 DBMET00112 0.655 0.004 DBMET02467 0.431 0.005 DBMET02468 | ||
| 0.809 | 0.001 | 0.809 | Benzodiazepine agonist | 0.194 0.005 DBMET01582 0.6 0.002 DBMET00348 0.479 0.003 DBMET00112 0.336 0.003 DBMET02467 0.178 0.005 DBMET02468 | ||
| 0.751 | 0.002 | 0.751 | GABA A receptor antagonist | 0.207 0.005 DBMET01582 0.497 0.003 DBMET00348 0.567 0.003 DBMET00112 0.355 0.004 DBMET02467 | ||
| 0.746 | 0.003 | 0.746 | GABA receptor agonist | 0.437 0.004 DBMET01582 0.588 0.003 DBMET00348 0.641 0.003 DBMET00112 0.478 0.004 DBMET02467 0.118 0.058 DBMET02468 | ||
| 0.738 | 0.003 | 0.738 | GABA receptor antagonist | 0.216 0.005 DBMET01582 0.486 0.003 DBMET00348 0.58 0.003 DBMET00112 0.359 0.004 DBMET02467 | ||
| 0.734 | 0.003 | 0.734 | GABA C receptor rho-3 antagonist | 0.441 0.045 DBMET01582 0.628 0.005 DBMET00348 0.621 0.005 DBMET00112 0.487 0.03 DBMET02467 0.3 0.116 DBMET02468 | ||
| 0.671 | 0.005 | 0.683 | Psychostimulant | 0.497 0.011 DBMET01582 0.528 0.009 DBMET00348 0.683 0.004 DBMET00112 0.538 0.008 DBMET02467 0.361 0.029 DBMET02468 | DBMET00112 | |
| 0.427 | 0.004 | 0.427 | Vasopressin 1 antagonist | 0.091 0.01 DBMET01582 0.118 0.008 DBMET00348 0.345 0.004 DBMET00112 0.103 0.009 DBMET02467 0.113 0.008 DBMET02468 | ||
| 0.501 | 0.087 | 0.536 | Antiinflammatory | 0.29 0.225 DBMET01582 0.536 0.073 DBMET00112 0.471 0.1 DBMET02468 | DBMET00112 | |
| 0.388 | 0.018 | 0.388 | Cyclic AMP phosphodiesterase inhibitor | 0.198 0.095 DBMET01582 0.26 0.059 DBMET00348 0.261 0.059 DBMET00112 | ||
| 0.365 | 0.003 | 0.365 | Vasopressin 1A antagonist | 0.083 0.007 DBMET01582 0.089 0.006 DBMET00348 0.266 0.004 DBMET00112 0.083 0.007 DBMET02467 0.094 0.005 DBMET02468 | ||
| 0.36 | 0.004 | 0.36 | GABA A receptor agonist | 0.102 0.036 DBMET01582 0.098 0.04 DBMET00348 0.267 0.005 DBMET00112 0.08 0.064 DBMET02467 | ||
| 0.357 | 0.004 | 0.357 | Antidiuretic hormone antagonist | 0.098 0.013 DBMET01582 0.126 0.009 DBMET00348 0.287 0.004 DBMET00112 0.113 0.01 DBMET02467 0.1 0.013 DBMET02468 | ||
| 0.338 | 0.004 | 0.338 | GABA C receptor rho-2 antagonist | 0.193 0.033 DBMET01582 0.252 0.011 DBMET00348 0.243 0.013 DBMET00112 0.185 0.038 DBMET02467 | ||
| 0.322 | 0.003 | 0.322 | Bromodomain-containing protein 4 inhibitor | 0.059 0.033 DBMET01582 0.222 0.004 DBMET00348 0.111 0.011 DBMET00112 0.05 0.046 DBMET02467 0.066 0.028 DBMET02468 | ||
| 0.274 | 0.003 | 0.274 | Bromodomain-containing protein 2 inhibitor | 0.085 0.065 DBMET01582 0.186 0.004 DBMET00348 0.152 0.008 DBMET00112 0.108 0.032 DBMET02467 0.088 0.058 DBMET02468 | ||
| 0.266 | 0.002 | 0.266 | Bromodomain-containing protein 3 inhibitor | 0.096 0.005 DBMET01582 0.223 0.003 DBMET00348 0.124 0.004 DBMET00112 0.101 0.005 DBMET02467 0.114 0.005 DBMET02468 | ||
| 0.22 | 0.004 | 0.22 | Oxytocin antagonist | 0.161 0.005 DBMET01582 0.119 0.009 DBMET00348 0.211 0.004 DBMET00112 0.134 0.007 DBMET02467 0.113 0.009 DBMET02468 | ||
| 0.212 | 0.007 | 0.212 | Interleukin 2 antagonist | 0.156 0.016 DBMET00348 0.103 0.083 DBMET00112 0.104 0.078 DBMET02468 | ||
| 0.175 | 0.013 | 0.175 | GABA C receptor rho-1 antagonist | 0.105 0.055 DBMET01582 0.119 0.041 DBMET00348 0.131 0.032 DBMET00112 | ||
| 0.18 | 0.033 | 0.18 | Glutamate receptor antagonist | 0.168 0.04 DBMET00112 | ||
| 0.164 | 0.023 | 0.164 | GABA C receptor antagonist | 0.101 0.076 DBMET01582 0.116 0.057 DBMET00348 0.126 0.047 DBMET00112 | ||
| 0.166 | 0.031 | 0.166 | Pregnane X receptor agonist | 0.137 0.081 DBMET00348 0.141 0.072 DBMET00112 0.155 0.044 DBMET02468 | ||
| 0.228 | 0.097 | 0.228 | Cardiotonic | |||
| 0.225 | 0.112 | 0.225 | Gastrin inhibitor | 0.22 0.119 DBMET00112 | ||
| 0.12 | 0.008 | 0.12 | Phosphodiesterase II inhibitor | 0.058 0.035 DBMET00348 0.089 0.014 DBMET00112 | ||
| 0.138 | 0.026 | 0.138 | Phosphodiesterase 7B inhibitor | 0.099 0.057 DBMET00348 0.09 0.071 DBMET00112 | ||
| 0.114 | 0.004 | 0.114 | Benzodiazepine antagonist | 0.069 0.007 DBMET00348 0.065 0.009 DBMET00112 0.051 0.024 DBMET02467 | ||
| 0.115 | 0.007 | 0.115 | Cholecystokinin A antagonist | 0.053 0.018 DBMET00112 0.055 0.018 DBMET02468 | ||
| 0.111 | 0.007 | 0.111 | Phosphodiesterase 2A inhibitor | 0.051 0.033 DBMET00348 0.08 0.014 DBMET00112 | ||
| 0.114 | 0.018 | 0.114 | Protein kinase B beta inhibitor | 0.091 0.032 DBMET01582 0.109 0.02 DBMET00348 0.073 0.052 DBMET00112 0.078 0.045 DBMET02467 | ||
| 0.102 | 0.008 | 0.102 | Cholecystokinin antagonist | 0.039 0.03 DBMET00348 0.054 0.023 DBMET00112 0.04 0.03 DBMET02468 | ||
| 0.102 | 0.01 | 0.102 | Phosphodiesterase 1C inhibitor | 0.069 0.03 DBMET00348 0.077 0.022 DBMET00112 | ||
| 0.139 | 0.05 | 0.139 | Cholesterol synthesis inhibitor | 0.12 0.065 DBMET00348 0.126 0.06 DBMET00112 0.098 0.09 DBMET02467 | ||
| 0.092 | 0.009 | 0.092 | Nicotinic acid receptor 1 agonist | 0.064 0.015 DBMET00348 0.037 0.033 DBMET00112 0.04 0.029 DBMET02468 | ||
| 0.298 | 0.215 | 0.298 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.148 | 0.066 | 0.158 | MAP kinase kinase 4 inhibitor | 0.137 0.092 DBMET01582 0.143 0.077 DBMET00348 0.135 0.1 DBMET00112 0.128 0.121 DBMET02467 0.158 0.048 DBMET02468 | DBMET02468 | |
| 0.092 | 0.012 | 0.092 | Phosphodiesterase 1A inhibitor | 0.058 0.046 DBMET00348 0.056 0.051 DBMET00112 | ||
| 0.098 | 0.022 | 0.098 | Purinergic P2 antagonist | |||
| 0.086 | 0.012 | 0.086 | Purinergic P2X antagonist | |||
| 0.138 | 0.069 | 0.138 | Nav1.6 sodium channel blocker | 0.132 0.078 DBMET01582 0.138 0.069 DBMET00348 0.112 0.109 DBMET02467 | ||
| 0.209 | 0.142 | 0.219 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.219 0.117 DBMET01582 0.199 0.168 DBMET00112 | DBMET01582 | |
| 0.086 | 0.019 | 0.086 | Phosphodiesterase 1B inhibitor | 0.058 0.044 DBMET00112 | ||
| 0.099 | 0.035 | 0.099 | Glutamate (mGluR) antagonist | 0.068 0.063 DBMET00112 | ||
| 0.132 | 0.071 | 0.132 | Sodium channel (voltage-gated) blocker | 0.126 0.078 DBMET00112 | ||
| 0.079 | 0.018 | 0.079 | Corticotropin releasing factor 2 receptor antagonist | |||
| 0.101 | 0.043 | 0.101 | Phosphodiesterase I inhibitor | |||
| 0.066 | 0.008 | 0.066 | Purinergic P2X7 antagonist | |||
| 0.075 | 0.019 | 0.075 | AMPA receptor antagonist | 0.042 0.04 DBMET01582 0.053 0.029 DBMET00348 0.066 0.022 DBMET00112 0.043 0.039 DBMET02467 | ||
| 0.084 | 0.034 | 0.084 | Glutamate (mGluR group I) antagonist | |||
| 0.068 | 0.018 | 0.068 | Glutamate (mGluR5) antagonist | |||
| 0.063 | 0.013 | 0.063 | Benzodiazepine inverse agonist | 0.047 0.031 DBMET01582 0.056 0.018 DBMET00112 | ||
| 0.112 | 0.065 | 0.112 | MAP kinase 13 inhibitor | 0.104 0.075 DBMET00348 | ||
| 0.057 | 0.012 | 0.057 | Vasopressin 2 antagonist | 0.035 0.021 DBMET00112 | ||
| 0.088 | 0.046 | 0.088 | Glycine receptor antagonist | 0.078 0.06 DBMET00348 0.077 0.062 DBMET00112 | ||
| 0.122 | 0.081 | 0.122 | Phosphodiesterase inhibitor | |||
| 0.081 | 0.04 | 0.082 | GABA B receptor agonist | 0.07 0.069 DBMET00348 0.082 0.038 DBMET00112 | DBMET00112 | |
| 0.087 | 0.05 | 0.087 | Histamine H1 receptor antagonist | |||
| 0.053 | 0.016 | 0.053 | GABA B receptor antagonist | 0.047 0.023 DBMET00112 | ||
| 0.234 | 0.198 | 0.234 | Analgesic | |||
| 0.105 | 0.07 | 0.105 | 5 Hydroxytryptamine 3A agonist | |||
| 0.043 | 0.011 | 0.082 | Benzodiazepine receptor peripheral-type antagonist | 0.066 0.004 DBMET01582 0.082 0.004 DBMET00348 0.033 0.026 DBMET00112 0.07 0.004 DBMET02467 | DBMET00348 | |
| 0.086 | 0.054 | 0.091 | mTOR complex 2 inhibitor | 0.091 0.045 DBMET01582 0.082 0.064 DBMET00348 | DBMET01582 | |
| 0.049 | 0.018 | 0.049 | Alpha 1L adrenoreceptor agonist | 0.041 0.034 DBMET00112 | ||
| 0.082 | 0.053 | 0.082 | Phosphodiesterase 3A inhibitor | |||
| 0.05 | 0.022 | 0.05 | Parathyroid hormone antagonist | 0.043 0.037 DBMET00348 0.047 0.027 DBMET00112 | ||
| 0.089 | 0.062 | 0.089 | Potassium channel activator | |||
| 0.071 | 0.044 | 0.071 | MAP kinase kinase 8 inhibitor | |||
| 0.127 | 0.102 | 0.131 | Thrombolytic | 0.131 0.098 DBMET00112 | DBMET00112 | |
| 0.142 | 0.123 | 0.244 | Anesthetic general | 0.192 0.079 DBMET01582 0.244 0.053 DBMET00348 0.197 0.076 DBMET02467 | DBMET00348 | |
| 0.122 | 0.103 | 0.124 | Diuretic | 0.124 0.1 DBMET00112 | DBMET00112 | |
| 0.231 | 0.216 | 0.231 | MAP kinase kinase 6 inhibitor | |||
| 0.025 | 0.013 | 0.025 | Corticotropin releasing factor 1 receptor antagonist | |||
| 0.039 | 0.029 | 0.047 | CF transmembrane conductance regulator antagonist | 0.039 0.03 DBMET00348 0.047 0.012 DBMET00112 0.043 0.018 DBMET02467 0.039 0.031 DBMET02468 | DBMET00112 | |
| 0.121 | 0.112 | 0.121 | Heat shock protein 90 antagonist | |||
| 0.194 | 0.185 | 0.194 | Antithrombotic | |||
| 0.044 | 0.036 | 0.044 | Purinergic P2X4 antagonist | |||
| 0.085 | 0.078 | 0.085 | DNA directed RNA polymerase inhibitor | |||
| 0.078 | 0.072 | 0.078 | CC chemokine 5 receptor agonist | |||
| 0.064 | 0.06 | 0.076 | MDM2 inhibitor | 0.065 0.053 DBMET00112 0.076 0.025 DBMET02468 | DBMET02468 | |
| 0.036 | 0.034 | 0.036 | 5 Hydroxytryptamine 2B agonist | |||
| 0.054 | 0.053 | 0.054 | 5 Hydroxytryptamine 2A agonist | |||
| 0.06 | 0.059 | 0.06 | Calcium channel P-type blocker | |||
| 0.015 | 0.016 | 0.028 | Sodium/hydrogen exchanger inhibitor | 0.028 0.005 DBMET02468 | DBMET02468 | |
| 0.072 | 0.074 | 0.082 | MAP kinase kinase 7 inhibitor | 0.082 0.04 DBMET01582 | DBMET01582 | |
| 0.014 | 0.022 | 0.019 | CC chemokine 9 receptor antagonist | 0.019 0.008 DBMET02468 | DBMET02468 | |
| 0.061 | 0.082 | 0.071 | Phosphodiesterase VIII inhibitor | 0.071 0.052 DBMET00112 | DBMET00112 | |
| 0.129 | 0.153 | 0.157 | Non-steroidal antiinflammatory agent | 0.157 0.107 DBMET02468 | DBMET02468 | |
| 0.044 | 0.076 | 0.059 | Cannabinoid CB1 receptor antagonist | 0.059 0.046 DBMET02468 | DBMET02468 | |
| 0.097 | 0.134 | 0.186 | Cytidine deaminase inhibitor | 0.186 0.054 DBMET01582 0.164 0.066 DBMET00348 0.138 0.085 DBMET02467 | DBMET01582 | |
| 0.125 | 0.167 | 0.43 | Aldehyde oxidase inhibitor | 0.43 0.043 DBMET02468 | DBMET02468 | |
| 0.045 | 0.09 | 0.094 | Cyclin B3 inhibitor | 0.094 0.031 DBMET00348 0.067 0.048 DBMET02467 | DBMET00348 | |
| 0.032 | 0.084 | 0.061 | Toll-Like receptor 8 antagonist | 0.061 0.03 DBMET00112 | DBMET00112 | |
| 0.131 | 0.184 | 0.261 | Interleukin agonist | 0.161 0.157 DBMET00112 0.261 0.071 DBMET02468 | DBMET02468 | |
| 0.148 | 0.204 | 0.191 | RNA-directed DNA polymerase inhibitor | 0.191 0.113 DBMET00112 0.19 0.115 DBMET02468 | DBMET00112 | |
| 0.103 | 0.171 | 0.141 | Pyruvate kinase inhibitor | 0.141 0.124 DBMET02468 | DBMET02468 | |
| 0.063 | 0.147 | 0.086 | Protein kinase C zeta inhibitor | 0.086 0.073 DBMET01582 0.084 0.078 DBMET00348 0.086 0.072 DBMET02467 | DBMET02467 | |
| 0.208 | 0.293 | 0.253 | 5 Hydroxytryptamine release inhibitor | 0.253 0.223 DBMET02468 | DBMET02468 | |
| 0.144 | 0.246 | 0.21 | Immunomodulator | 0.21 0.152 DBMET00112 | DBMET00112 | |
| 0.086 | 0.194 | 0.174 | Mannose-6-phosphate isomerase inhibitor | 0.174 0.046 DBMET02468 | DBMET02468 | |
| 0.043 | 0.156 | 0.06 | Kallikrein 7 inhibitor | 0.06 0.055 DBMET00348 | DBMET00348 | |
| 0.064 | 0.183 | 0.092 | Glutamate release inhibitor | 0.092 0.057 DBMET02468 | DBMET02468 | |
| 0.054 | 0.174 | 0.095 | NADH dehydrogenase inhibitor | 0.095 0.049 DBMET01582 0.081 0.072 DBMET02467 0.085 0.065 DBMET02468 | DBMET01582 | |
| 0.154 | 0.276 | 0.197 | 5 Hydroxytryptamine uptake stimulant | 0.197 0.157 DBMET02468 | DBMET02468 | |
| 0.159 | 0.287 | 0.312 | Calcium channel activator | 0.312 0.08 DBMET02468 | DBMET02468 | |
| 0.072 | 0.201 | 0.099 | Interleukin 8 antagonist | 0.099 0.098 DBMET00348 | DBMET00348 | |
| 0.047 | 0.177 | 0.118 | HIV-1 integrase (Overall Integration) inhibitor | 0.118 0.04 DBMET02468 | DBMET02468 | |
| 0.007 | 0.141 | 0.023 | 4-Hydroxyphenylpyruvate dioxygenase inhibitor | 0.023 0.004 DBMET02468 | DBMET02468 | |
| 0.117 | 0.254 | 0.269 | Thyroid hormone beta antagonist | 0.269 0.106 DBMET02468 | DBMET02468 | |
| 0.009 | 0.147 | 0.038 | Urate transporter 1 inhibitor | 0.038 0.028 DBMET02468 | DBMET02468 | |
| 0.04 | 0.186 | 0.1 | Alcohol dehydrogenase inhibitor | 0.1 0.053 DBMET02468 | DBMET02468 | |
| 0.095 | 0.255 | 0.142 | Succinate dehydrogenase inhibitor | 0.142 0.128 DBMET02468 | DBMET02468 | |
| 0.01 | 0.17 | 0.031 | Liver X receptor beta agonist | 0.031 0.026 DBMET02468 | DBMET02468 | |
| 0.128 | 0.294 | 0.325 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.325 0.048 DBMET01582 0.306 0.06 DBMET00348 0.295 0.067 DBMET02467 | DBMET01582 | |
| 0.022 | 0.191 | 0.082 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.082 0.02 DBMET01582 | DBMET01582 | |
| 0.024 | 0.196 | 0.064 | Protein kinase C beta inhibitor | 0.064 0.06 DBMET01582 | DBMET01582 | |
| 0.104 | 0.28 | 0.273 | Thyroid hormone antagonist | 0.273 0.109 DBMET02468 | DBMET02468 | |
| 0.068 | 0.249 | 0.157 | Arachidonic acid antagonist | 0.157 0.081 DBMET02468 | DBMET02468 | |
| 0.059 | 0.245 | 0.112 | Toll-Like receptor antagonist | 0.112 0.099 DBMET00112 | DBMET00112 | |
| 0.042 | 0.247 | 0.088 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.088 0.068 DBMET02468 | DBMET02468 | |
| 0.066 | 0.279 | 0.146 | Hexokinase inhibitor | 0.146 0.084 DBMET02468 | DBMET02468 | |
| 0.042 | 0.27 | 0.212 | Amylase inhibitor | 0.212 0.04 DBMET02468 | DBMET02468 | |
| 0.038 | 0.269 | 0.096 | Protein kinase C gamma inhibitor | 0.096 0.085 DBMET01582 | DBMET01582 | |
| 0.094 | 0.353 | 0.155 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.155 0.137 DBMET01582 | DBMET01582 | |
| 0.043 | 0.323 | 0.092 | Nav1.1 sodium channel blocker | 0.092 0.076 DBMET01582 | DBMET01582 | |
| 0.064 | 0.344 | 0.179 | Prostaglandin dehydrogenase inhibitor | 0.179 0.173 DBMET02468 | DBMET02468 | |
| 0.015 | 0.306 | 0.068 | Protein kinase C eta inhibitor | 0.068 0.03 DBMET01582 | DBMET01582 | |
| 0.046 | 0.359 | 0.134 | Interleukin antagonist | 0.134 0.132 DBMET02468 | DBMET02468 | |
| 0.046 | 0.359 | 0.09 | Adenylate kinase inhibitor | 0.09 0.088 DBMET01582 | DBMET01582 | |
| 0.034 | 0.35 | 0.105 | Alpha-N-acetylglucosaminidase inhibitor | 0.105 0.094 DBMET01582 | DBMET01582 | |
| 0.07 | 0.405 | 0.222 | DNA synthesis inhibitor | 0.222 0.092 DBMET01582 | DBMET01582 | |
| 0.029 | 0.378 | 0.112 | Protein kinase C nu inhibitor | 0.112 0.102 DBMET01582 | DBMET01582 | |
| 0.023 | 0.374 | 0.115 | Protein kinase C mu inhibitor | 0.115 0.045 DBMET01582 0.085 0.073 DBMET00348 | DBMET01582 | |
| 0.027 | 0.381 | 0.094 | Uric acid excretion stimulant | 0.094 0.06 DBMET02468 | DBMET02468 | |
| 0.054 | 0.424 | 0.17 | DNA damaging | 0.17 0.145 DBMET01582 | DBMET01582 | |
| 0.061 | 0.476 | 0.294 | Cholesterol antagonist | 0.294 0.095 DBMET02468 | DBMET02468 | |
| 0.038 | 0.48 | 0.264 | Alpha-glucosidase inhibitor | 0.264 0.179 DBMET02468 | DBMET02468 | |
| 0.099 | 0.625 | 0.517 | Calcium channel L-type activator | 0.309 0.15 DBMET01582 0.517 0.022 DBMET02468 | DBMET02468 | |
| 0.017 | 0.576 | 0.126 | Dual specificity phosphatase 3 inhibitor | 0.126 0.121 DBMET02468 | DBMET02468 | |
| 0.018 | 0.655 | 0.118 | Farnesoid X receptor antagonist | 0.118 0.108 DBMET02468 | DBMET02468 | |
| 0.009 | 0.646 | 0.033 | Elastase 2B inhibitor | 0.033 0.017 DBMET02468 | DBMET02468 | |
| 0.009 | 0.646 | 0.033 | Elastase 3A inhibitor | 0.033 0.017 DBMET02468 | DBMET02468 | |
| 0.009 | 0.646 | 0.033 | Elastase 3B inhibitor | 0.033 0.017 DBMET02468 | DBMET02468 | |
| 0.016 | 0.696 | 0.112 | Interleukin 1 antagonist | 0.112 0.101 DBMET02468 | DBMET02468 | |
| 0.019 | 0.727 | 0.111 | Interleukin 1b antagonist | 0.111 0.07 DBMET02468 | DBMET02468 | |
| 0.052 | 0.807 | 0.522 | Interleukin 2 agonist | 0.522 0.006 DBMET02468 | DBMET02468 | |
| 0.002 | 0.948 | 0.038 | 1,3-Beta-glucan synthase inhibitor | 0.038 0.004 DBMET01582 0.034 0.008 DBMET00348 0.034 0.007 DBMET02467 | DBMET01582 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |